The technology transfer process translates discoveries into products or services that can benefit the public. There are many commercialization routes, and Cedars-Sinai's Technology Ventures is here to help inventors navigate the process.
A patent is an exclusive right granted for an invention, that excludes others, for a limited period of time, from making, using or selling the invention without the inventor's permission. A patent does not grant the inventor(s) the right to practice their invention.
Once a lead shows interest in licensing, due diligence is performed to investigate the company's background, experience and reputation. If the company appears to be a good candidate, Technology Ventures initiates negotiation of a license agreement. The goal of the negotiation is to reach a fair and balanced agreement between the licensee and Cedars-Sinai.
Cedars-Sinai shares revenue with its inventors and reinvests in research to generate a new cycle of discoveries that will eventually join the technology transfer pipeline.